Search PubMed⌕ Search

Biomedical subjects

P Juto

Publications and source records attributed to P Juto.

At least 73 records · Page 4Linked to original sources

Specific serum IgA, IgG and IgM antibody determination by a modified indirect ELISA-technique in primary and recurrent herpes simplex virus infection.

Twenty-three patients with a herpetic infection as diagnosed by a positive culture of herpes simplex virus (HSV) were studied with respect to serological responses of IgA, IgG and IgM antibodies in paired serum samples by an indirect (sandwich) enzyme linked immunosorbent assay (ELISA). Eight of the patients had a primary infection and 15 a recurrent one. In the ELISA test a detergent treated cell lysate of HSV type 1 was used as antigen. In the IgM assay all sera were pretreated with antihuman IgG with the purpose to precipitate IgG of the samples. The conjugate was a F(ab)2-fragment of antihuman-IgM. In primary infections all patients had significant titre rises of IgG and presence of high IgM titres in the convalescent serum. IgA antibodies were found in all of them, while titre rises were detected in 5/8. In recurrent infections titre rises of IgG and IgA antibodies were found in 4 and 5, respectively. Six had detectable IgM in one or both of the paired samples. The IgG titres were higher in recurrent infections than in primary, in contrast to IgM of which much higher titres were found in primary infections. It is concluded that in primary infections a conclusive serological diagnosis was established in all patients, whereas in recurrent infections this was achieved in two of three patients. The indirect ELISA method used for IgM detection was sensitive, reliable and convenient. Interfering rheumatoid factor was effectively eliminated by treatment with antihuman IgG.

Adolescent↗

Incidence and geographic distribution of serologically verified cases of nephropathia epidemica in Sweden.

A nationwide survey of hospitalized, serologically verified adult nephropathia epidemica cases in Sweden from 1978 to 1981 was performed. Serum was collected from 1,063 patients with a diagnosis of nephropathia epidemica or one of 10 other renal diseases with related symptoms. Sera were analyzed by indirect immunofluorescence technique for the presence of immunoglobulin G antibodies to Hantaan virus, causative agent of Korean hemorrhagic fever that cross-reacts with the nephropathia epidemica agent. Antibodies were present in 368 patients, 355 of whom also fulfilled four or more of six criteria for clinical diagnosis of nephropathia epidemica. The male:female ratio was 2.7:1. The total number of cases in Sweden varied between 26 and 144 per year, which coincided with the fluctuations in small rodent populations. The highest incidence was found in Västerbotten County, with a maximum crude incidence rate of 23.5 cases per 100,000 inhabitants per year. Mean crude incidence in Sweden during the study period was 1.3 cases per 100,000 inhabitants per year. The southernmost cases lived in proximity to the 59th parallel. Thus, nephropathia epidemica was found to be prevalent south of the 60th parallel, which was previously assumed to be its southern boundary.

Adolescent↗

Detection of specific serum immunoglobulin M in nephropathia epidemica (Scandinavian epidemic nephropathy) by a biotin-avidin-amplified immunofluorescence method.

A biotin-avidin-amplified indirect immunofluorescence method was used to demonstrate specific serum immunoglobulin M (IgM) antibodies in nephropathia epidemica, the Scandinavian type of hemorrhagic fever with renal syndrome. The antigen in the test was the cross-reacting agent of Korean hemorrhagic fever, Hantaan virus. Sixty-two serum samples from 15 patients with clinically typical nephropathia epidemica were analyzed. Eleven patients had specific IgM in one or more serum samples. The IgM could be demonstrated from day 2 up to day 37, and all patients had detectable specific IgM within 15 days after the onset of disease. In 49 control serum samples, no specific IgM could be detected, indicating a high specificity for the method. The findings demonstrate that the biotin-avidin-amplified immunofluorescence IgM assay is a useful tool in the diagnosis of early nephropathia epidemica disease.

Adult↗

Clinical and immunological effects of oral immunotherapy with a standardized birch pollen extract.

Oral immunotherapy (IT) was evaluated in a pilot study in two centres in children aged 8-15 years with allergic rhinoconjunctivitis. High doses (up to 20 X 10(6) BU monthly) of a defined freeze-dried birch pollen extract administered in enteric-coated gelatine capsules were given either daily for seven consecutive days every month or once weekly. Symptom scores, as assessed by sneezing, dripping and blockage of the nose, and redness, itching and swelling of the eyes, were significantly lower in treated patients compared to untreated, or placebo treated controls after 3 to 5 months of therapy. In all the 16 treated, but only in three of eight untreated patients, the scores were lower during the pollen season 1982 than during the pollen season preceding the treatment period, despite comparable pollen counts during the two seasons. One year after beginning treatment the reactivity in conjunctival provocation tests was decreased about 10-fold (P less than 0.001) in the patients receiving more than 2 X 10(5) BU monthly compared to about two-fold in patients receiving lower doses, or placebo. Increased levels of IgE antibodies directed against birch pollen were recorded in the serum and saliva of most patients after 3-4 months of active IT. In contrast, IgG antibody responses were poor in most of the patients. Side effects, particularly from the gastrointestinal tract, appeared in all treated children. In one of them a systemic reaction occurred during IT. The study indicates that properly performed oral IT with a potent birch allergen extract in enteric-coated capsules may be effective.

Administration, Oral↗

Gliadin-specific serum immunoglobulins A, E, G, and M in childhood: relation to small intestine mucosal morphology.

An enzyme-linked immunosorbent assay technique was developed to determine serum antigliadin antibodies of the IgA, IgE, IgG, and IgM classes. The antibody level of each serum specimen was expressed as an index value, i.e., optical density of test serum/optical density of cutoff, where cutoff was calculated for each immunoglobulin class as the mean + 3 SD for six healthy controls. Indices for each immunoglobulin class were determined in 69 children who were admitted for their first small intestinal mucosal biopsy due to either symptoms of malabsorption compatible with celiac disease, or short stature without other symptoms. Especially raised levels of antigliadin IgA antibodies in serum correlated strongly with villous atrophy and in infants less than or equal to 3 years of age were invariably elevated above controls, provided they were on a gluten-containing diet. Raised levels of IgG and IgE antibodies to gluten were often seen in children with normal mucosal morphology, i.e., when symptoms were due to other gastrointestinal disorders than celiac disease. It is concluded that determination of antigliadin IgA antibodies in children less than or equal to 3 years is a useful screening test before small intestinal biopsy, especially in children where the indication for biopsy is not otherwise obvious. The method can also be used to assess the results of therapy and, conceivably, compliance.

Atrophy↗

Human milk stimulates B cell function.

The effect of human milk on B cell function was studied by using murine spleen cells stimulated with suboptimal doses of lipopolysaccharide. Cell free, defatted, filtered colostrum as well as mature breast milk showed an enhancing effect on B cell proliferation and generation of antibody secretion, but this was not seen with formula milk. The activity was heat sensitive and resisted overnight dialysis. It is suggested that this could represent an important immunological mechanism explaining the anti-infectious properties of breast milk.

Animals↗

Blood lymphocyte proliferation response to pollen extract as a monitor of immunotherapy.

In a study of immunotherapy 41 children with seasonal rhinoconjunctivitis due to deciduous tree pollen allergy were monitored by means of symptom scoring, patient self-evaluation, conjunctival provocation tests and lymphocyte proliferation in vitro to the allergen. The lymphocyte responsiveness to birch pollen decreased significantly during the first year of immunotherapy. However, neither the lymphocyte responsiveness before treatment nor changes in lymphocyte reactivity during the immunotherapy correlated with the clinical efficacy of the therapy as evaluated by changes in symptom scores, self-evaluation or conjunctival provocation test changes in the individual patients. The results indicate that lymphocyte responsiveness to an allergen cannot be used to select patients for immunotherapy, i.e. to predict whether a patient would benefit from immunotherapy or not, or to evaluate the effects of immunotherapy after beginning the treatment. However, lymphocyte proliferation response to an allergen indicates clinical sensitivity.

Adolescent↗

Influence of type of feeding on lymphocyte function and development of infantile allergy.

Symptom scores indicating infantile allergy were recorded longitudinally in a group of infants during the first year of life. The symptom scores were related to duration of breast-feeding. Lymphocyte function, measured as the proliferative responsiveness to PHA-stimulation, was related to feeding with breast-milk or cow's milk. Babies with a short duration of breast-feeding; i.e. 1 month or less had significantly higher symptom scores at the ages of 1 month (P less than 0.05), 3 months (P less than 0.05), 6 months (P less than 0.001) and 12 months (P less than 0.05), than babies who were breast-fed for more than 1 month. The lymphocyte responsiveness to PHA was significantly higher at 3 and 6 months in babies who were fed cow's milk compared with those who were solely or partially breast-fed (P less than 0.05 and P less than 0.01 respectively). There was no correlation between symptom scores and lymphocyte responsiveness. It is concluded that infantile allergy is more common in babies with a short duration of breast-feeding and that feeding with cow's milk, compared to breast-feeding, causes a changed lymphocyte reactivity to PHA, which latter finding indicates an altered T-cell function between the two feeding groups.

Bottle Feeding↗

Elevated serum immunoglobulin E in T cell-deficient infants fed cow's milk.

Serum IgE levels at various ages during infancy were related to the number of T cells assessed at the age of 1 mo and type of feeding. Cow's milk-fed babies with low T cell counts had higher IgE at the ages of 3 and 6 mo than breast-fed babies with low T cell counts. Of the babies fed cow's milk, those with low T cell counts had higher IgE levels than those with normal T cell counts. Onset of cow's milk feeding before the age of 3 mo in babies with low T cell counts was associated with continuously elevated IgE during the first year of life, as compared with babies with normal T cell counts. However, when cow's milk feeding was instituted after the age of 3 mo such a difference was not noted. It is concluded that in T cell-deficient infants there might exist a critical period during which onset of cow's milk feeding is associated with subsequently increased IgE synthesis.

Aging↗

Serum IgE in infants and influence of type of feeding.

Serum IgE in healthy infants was followed longitudinally during the first year of life and was related to heredity for allergy and type of feeding. During the first 6 months of life there were no significant differences of serum IgE levels in relation to presence or absence of heredity for allergy and type of feeding. IgE levels determined at the age of 12 months in infants who were weaned after the age of 6 months were significantly higher than in infants weaned before that age (P < 0.05). When the time periods had passed, following onset of cow's milk-feeding and complete cassation of breast-feeding, and were correlated to IgE at the age of 12 months, there were inverse significant correlations; i.e. the earlier the onset of cow's milk-feeding the lower the IgE and the later the cessation of breast-feeding the higher the IgE. This was particularly obvious as regards infants with heredity for allergy and a long duration of breast-feeding (r = -0.43; P < 0.01). Infants with heredity for allergy subjected to a hypoallergenic diet adhered to for 6 months had significantly higher IgE at the age of 12 months than infants with similar heredity but a normal diet (P < 0.05). The results indicate that serum IgE during late infancy is influenced by both genetic factors and the time of introduction of cow's milk formula in the diet and the time of cessation of breast-feeding.

Aging↗

T lymphocytes and blood eosinophils in early infancy in relation to heredity for allergy and type of feeding.

T lymphocytes in 50 one-month-old infants were determined and correlated to heredity for allergy, blood eosinophil counts, and type of feeding. It was found that infants with heredity for atopy had significantly lower relative numbers of T lymphocytes than infants without heredity (p less than 0.05). This difference was particularly obvious in heredity for asthma on the paternal side (p equals 0.001). There was an inverse correlation between T lymphocyte counts and blood eosinophil counts in infants who were cow's milk-fed; i.e., low T lymphocyte counts were associated with high blood eosinophil counts (r = -0.59, p less than 0.01). T lymphocyte counts were not correlated to the type of feeding, whereas blood eosinophils were significantly higher in the cow's milk-fed than in the breast-fed group (p less than 0.01). The results suggest that atopic allergy may be associated with a genetically determined lymphocyte defect.

Asthma↗

Treatment of infantile atopic dermatitis with a strict elimination diet.

Of twenty-one infants with atopic dermatitis, twenty were treated with a strict elimination diet for a period of up to 6 weeks. Seven infants healed and twelve improved. The infants who healed were less than 6 months old and had had a short duration of dermatitis. For one infant the skin condition was unchanged. Another infant was breast-fed throughout the period with dermatitis. Blood eosinophilia and/or elevated serum IgE commonly found on admission decreased significantly (P less than 0.01) during the diet period. On challenge with cows' milk, twelve infants were considered as intolerant. At the age of 2 years the dermatitis had cleared in all but four children. Of these four children, two were still cows' milk intolerant. Another two infants were also cows' milk intolerant, but without dermatitis.

Animals↗

Clinical characteristics of nephropathia epidemica in Sweden: prospective study of 74 cases.

Clinical symptoms and laboratory measures of renal and liver function, coagulation, and inflammatory parameters were prospectively studied in 74 hospitalized patients (14-74 years of age) with serologic evidence of nephropathia epidemica. The most common clinical findings were acute onset of symptoms, fever (greater than or equal to 38 degrees C), thirst, headache, nausea, back pain, vomiting, myalgia, and abdominal pain. Twenty-seven patients (37%) had hemorrhagic manifestations, i.e., epistaxis, melena, hematemesis, petechial bleeding, macroscopic hematuria, or metrorrhagia. Disseminated intravascular coagulation developed in four patients. Fifty-one percent had thrombocytopenia. Proteinuria was recorded for all patients, while hematuria and glucosuria were noted for 85% and 58%, respectively. Serum creatinine levels were elevated in 71 (96%) of the patients. Levels of C-reactive protein or erythrocyte sedimentation rates were elevated in all cases, usually to levels found in serious bacterial diseases. Sixty-six (89%) of the patients were followed for up to 7 months, at which time all had recovered clinically. No patient died or required dialysis. We conclude that nephropathia epidemica in Sweden has a clinical picture similar to that of hemorrhagic fevers in other parts of the world, but with a milder course and a better prognosis.

Adolescent↗